These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 21871283)
21. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
22. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273 [TBL] [Abstract][Full Text] [Related]
23. High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience. Bojan M; Boulat C; Peperstraete H; Pouard P Paediatr Anaesth; 2012 Aug; 22(8):818-25. PubMed ID: 22416677 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. Graham EM; Atz AM; Gillis J; Desantis SM; Haney AL; Deardorff RL; Uber WE; Reeves ST; McGowan FX; Bradley SM; Spinale FG J Thorac Cardiovasc Surg; 2012 May; 143(5):1069-76. PubMed ID: 22075061 [TBL] [Abstract][Full Text] [Related]
25. Bleeding in cardiac surgery: the use of aprotinin does not affect survival. Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459 [TBL] [Abstract][Full Text] [Related]
26. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial. Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082 [TBL] [Abstract][Full Text] [Related]
27. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Székely A; Cserép Z; Sápi E; Breuer T; Nagy CA; Vargha P; Hartyánszky I; Szatmári A; Treszl A Ann Thorac Surg; 2009 Jan; 87(1):187-97. PubMed ID: 19101294 [TBL] [Abstract][Full Text] [Related]
28. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R; N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196 [TBL] [Abstract][Full Text] [Related]
29. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia. Riddell RE; Buth KJ; Sullivan JA Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043 [TBL] [Abstract][Full Text] [Related]
30. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766 [TBL] [Abstract][Full Text] [Related]